Co-amilozide
Brand names: Moduretic
Co-amilozide is a fixed-dose combination of amiloride (a potassium-sparing diuretic) and hydrochlorothiazide (a thiazide diuretic), used in hypertension and oedema.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
Hydrochlorothiazide inhibits sodium-chloride reabsorption in the distal convoluted tubule, while amiloride blocks epithelial sodium channels to reduce the associated potassium loss.
Prescribing in practice
- Monitor for hyperkalaemia from the amiloride component, particularly in renal impairment or with ACE inhibitors, ARBs or potassium supplements.
- Thiazides can cause hyponatraemia, hypomagnesaemia, hyperglycaemia, hyperuricaemia and may precipitate gout.
- Avoid in significant renal impairment and do not combine with other potassium-sparing agents or potassium supplements.
Monitoring
Monitor serum electrolytes including potassium and sodium, with renal function and blood pressure.
Counselling the patient
- Take the dose in the morning to reduce night-time urination.
- Report palpitations, muscle weakness, confusion or marked dizziness.
- Avoid potassium-containing salt substitutes unless advised.
Evidence & guidelines
Thiazide-type diuretics are an established option in NICE hypertension guidance; the potassium-sparing combination is used to offset thiazide-induced hypokalaemia.
Reference: Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Acute Heart Failure · ESC 2021 Heart Failure Guidelines; NICE NG106
- NSTEMI / Unstable Angina · ESC 2020 NSTEMI Guidelines; NICE NG185
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines